|Articles|August 1, 2018
- BioPharm International-08-01-2018
- Volume 31
- Issue 8
BioPharm International, August 2018 Issue (PDF)
Click the title above to open the BioPharm International August 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
The Search for Next-Gen Expression Systemsabout 8 years ago
FDA Is Not Playing Games with Biosimilarsabout 8 years ago
Expectations for Residual Impurity Analysis Continue to Riseabout 8 years ago
E&L Risk Assessment for Biologic Drug Productsabout 8 years ago
Submitting Extractables and Leachables Data to Regulatorsabout 8 years ago
A New Paradigm in Drug Developmentabout 8 years ago
Maintaining Cell Line Integrityabout 8 years ago
FDA Seeks to Revive Quality Metrics InitiativeAdvertisement
Advertisement
Advertisement

